Is There a Vaccine to Prevent Covet 19?

The authorization for tixagevmab, soleva mab, also known as evi shelld, was based on face tr clinical trial called provent. In that study, waste plocibo controlled study that it reduced the likelihood of developing symptomatic covet 19 by about 80%. The other group that's authorized to receive tik gevmapsegavemab are those people who have had a serious adverse reaction to evacin and can't complete a vacion series. So i have been recommending tiivmasaleme for immuno compromised individuals.